题名 | Clinical significance of miR-155 expression in breast cancer and effects of miR-155 ASO on cell viability and apoptosis |
作者 | |
发表日期 | 2012-04 |
发表期刊 | ONCOLOGY REPORTS 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Article |
关键词 | breast neoplasms microRNAs microRNA-155 clinicopathological features antisense oligonucleotide viability apoptosis |
其他关键词 | MICRORNA EXPRESSION ; PROGNOSTIC-FACTORS ; GROWTH ; CARCINOMA ; TARGETS ; INFLAMMATION ; SURVIVAL ; GENE ; LYMPHOMAS ; PATHWAYS |
摘要 | Accumulating evidence shows that mircroRNAs (miRNAs) play a vital role in tumorigenesis. miR-155 is one of the most multifunctional miRNAs whose overexpression has been found to be associated with different types of cancer including breast cancer. To further determine the potential involvement of miR-155 in breast cancer, we evaluated the expression levels of miR-155 by real-time PCR and correlated the results with clinicopathological features. Matched non-tumor and tumor tissues of 42 infiltrating ductal carcinomas and 3 infiltrating lobular carcinomas were analyzed for miR-155 expression by real-time PCR. Further, we used an antisense technique to inhibit miR-155 expression in vitro. WST-8 test was performed to evaluate cell viability and apoptosis assay was used to investigate the effect of the miR-155 antisense oligonucleotide (miR-155 ASO) on HS578T cell death. The expression levels of miR-155 were significantly higher in tumor tissues than the levels in matched non-tumor tissues (P<0.001). Up-regulated miR-155 expression was associated with lymph node positivity (P=0.034), higher proliferation index (Ki-67 >10%) (P=0.019) and advanced breast cancer TNM clinical stage (P=0.002). Interestingly, we next found that miR-155 expression levels had close relations with ER status (P=0.041) and PR status (P=0.029). Transfection efficiency detected by flow cytometry was higher than 70%, the WST-8 test showed that viability of HS578T cells was greatly reduced after transfection with miR-155 ASO compared with the scramble (SCR) group or the liposome group. The Annexin V-FITC/PI assay also indicated that transfection with miR-155 ASO promoted apoptosis. |
资助项目 | Wenzhou Science and Technology Bureau [Y20080081, Y20100008] |
出版者 | SPANDIDOS PUBL LTD |
出版地 | ATHENS |
ISSN | 1021-335X |
EISSN | 1791-2431 |
卷号 | 27期号:4页码:1149-1155 |
DOI | 10.3892/or.2012.1634 |
页数 | 7 |
WOS类目 | Oncology |
WOS研究方向 | Oncology |
WOS记录号 | WOS:000301757600036 |
收录类别 | SCIE ; PUBMED ; SCOPUS |
URL | 查看原文 |
PubMed ID | 22245916 |
PMC记录号 | PMC3583512 |
SCOPUSEID | 2-s2.0-84863043199 |
通讯作者地址 | [Guo, Gui-Long]Wenzhou Med Coll, Affiliated Hosp 1, Dept Oncol, 2 Fu Xue Rd, Wenzhou 325000, Zhejiang, Peoples R China. |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/15718 |
专题 | 附属第一医院_肿瘤内科 |
通讯作者 | Guo, Gui-Long |
作者单位 | 1.Wenzhou Med Coll, Affiliated Hosp 1, Dept Oncol, Wenzhou 325000, Zhejiang, Peoples R China; 2.Jiaxing Matern & Child Hlth Care Hosp, Dept Breast Surg, Jiaxing 314000, Zhejiang, Peoples R China |
第一作者单位 | 附属第一医院_肿瘤内科 |
通讯作者单位 | 附属第一医院_肿瘤内科 |
第一作者的第一单位 | 附属第一医院_肿瘤内科 |
推荐引用方式 GB/T 7714 | Zheng, Shu-Rong,Guo, Gui-Long,Zhang, Wei,et al. Clinical significance of miR-155 expression in breast cancer and effects of miR-155 ASO on cell viability and apoptosis[J]. ONCOLOGY REPORTS,2012,27(4):1149-1155. |
APA | Zheng, Shu-Rong., Guo, Gui-Long., Zhang, Wei., Huang, Guan-Li., Hu, Xiao-Qu., ... & Zhang, Xiao-Hua. (2012). Clinical significance of miR-155 expression in breast cancer and effects of miR-155 ASO on cell viability and apoptosis. ONCOLOGY REPORTS, 27(4), 1149-1155. |
MLA | Zheng, Shu-Rong,et al."Clinical significance of miR-155 expression in breast cancer and effects of miR-155 ASO on cell viability and apoptosis".ONCOLOGY REPORTS 27.4(2012):1149-1155. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论